Cold plasma for cancer in the abdomen
Part of Cancer clinical trials.
This trial tests whether a special cold gas (called cold atmospheric plasma) can help destroy cancer cells left in the abdomen after surgery. It's for people with certain cancers that have spread to the belly lining.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that has spread to the lining of your abdomen (called peritoneal metastases)
- You are having surgery to remove as much of the cancer as possible
- You are at least 18 years old
- You give written permission (informed consent) to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver chemotherapy directly into the abdomen using a spray (called PIPAC) in people with stomach cancer that has spread to the lining of the belly. The aim is to see if it can help control the cancer with fewer side effects.
This study tests whether applying cold atmospheric plasma (an ionized gas) during surgery can reduce wound complications in patients with poor blood flow to their legs. If you're having surgery to treat narrowed arteries in your groin area and have risk factors for wound healing problems, this trial may help prevent infections and other healing issues.
This trial tests whether cold atmospheric plasma—a gentle, gas-based treatment—can help heal wounds where tubes enter the body for life support. It might offer a new way to care for these delicate spots.
This study tests whether a treatment called 'cold atmospheric plasma' (similar to a gentle, cool gas) can improve moderate-to-severe acne. It might offer a new, drug-free option for people with many pimples or cysts.
This Phase 2 study tests a treatment that warms chemotherapy and delivers it directly into the abdomen to treat pancreatic cancer that has spread to the lining of the belly (peritoneum). You may be eligible if you completed earlier chemotherapy and your body shows signs the cancer is responding, with limited spread in the abdomen.
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
Hear when a new Cold Atmospheric Plasma (CAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.